Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease
Cochrane Reviews,  Clinical Article

Walters JAE et al. – The authors based assessment of the efficacy of short compared to longer duration systemic corticosteroid therapy for acute exacerbations of chronic obstructive pulmonary disease (COPD) in this review on four of the seven included studies for which data were available. The finding in this review that there is no significant increase in treatment failure with shorter systemic corticosteroid treatment for seven days or less for acute exacerbations of COPD, does not give conclusive evidence to recommend change in clinical practice due to a wide confidence interval around the estimate of effect.

Methods
  • The authors searched the Cochrane Airways Group Register of Trials (to April 2011) Cochrane Central Register of Controlled Trials (to April 2011), MEDLINE (from 1950 to October 2010), EMBASE (from 1980 to October 2010) and the reference lists of articles.
  • Randomised controlled trials comparing different durations of SC (seven days or fewer or more than seven days).
  • Other interventions, e.g. bronchodilators and antibiotics, were standardised; studies in other lung diseases were excluded, unless data on participants with COPD were available.
  • Two review authors independently extracted data that were pooled them using Review Manager 5.
  • The authors sought missing data from authors of studies published as abstracts only.

Results
  • The authors identified seven studies including 288 participants; two studies were fully published and five were published as abstracts.
  • The authors obtained data for two studies published as abstracts from authors; these two abstracts and the two full papers contributed to meta–analysis.
  • No study specified COPD diagnostic criteria and only one specified exacerbation criteria.
  • Short course treatment varied between three and seven days and longer duration 10 to 15 days, at equivalent daily doses of corticosteroids; five studies used oral prednisolone (dose 30 mg, four studies, one tapered dose) and two studies used intravenous corticosteroid treatment.
  • Mean ages of participants ranged from 64 to 73 years.
  • The authors assessed the risk of allocation and blinding bias as low for these studies.
  • Primary outcomes: risk of treatment failure did not differ significantly by treatment duration, but the confidence interval (CI) was too wide to conclude equivalence (odds ratio (OR) 0.94, 95% CI 0.38 to 2.36) (three studies, n = 158).
  • Forced expiratory volume in 1 second (FEV1) did not differ significantly when measured up to seven days (mean difference (MD) 0.07 L, 95% CI 0.19 to 0.05) or after seven days (MD 0.02 L, 95% CI 0.10 to 0.06) (four studies, n = 197).
  • The likelihood of an adverse event (four studies, n = 102) did not differ significantly by treatment duration, but again the CI was wide (OR 0.58, 95% CI 0.14 to 2.40).

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pulmonology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pulmonology Articles

1 Breathing in diesel exhaust leads to changes “deep under the hood” The University of British Columbia Health News, January 12, 2015

2 Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4) European Respiratory Journal , January 15, 2015    Clinical Article

3 Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients Full Text Respiratory Research, December 19, 2014    Free full text    Clinical Article

4 The effects of vitamin D supplementation on airway functions in mild to moderate persistent asthma Annals of Allergy, Asthma, and Immunology, August 7, 2014    Clinical Article

5 Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): A randomised, double-blind, placebo-controlled trial The Lancet Respiratory Medicine, May 15, 2014    Clinical Article

6 Cytotoxic agents in sarcoidosis: Which one should we choose? Current Opinion in Pulmonary Medicine, August 15, 2014    Review Article

7 Urinary albumin-creatinine ratio, estimated glomerular filtration rate, and all-cause mortality among US adults with obstructive lung function Chest, January 9, 2015    Clinical Article

8 Multicentric study on the beta-blocker use and relation with exacerbations in COPD Respiratory Medicine, June 19, 2014    Clinical Article

9 Elevated plasma interleukin-35 levels predict poor prognosis in patients with non-small cell lung cancer Tumor Biology, December 24, 2014    Clinical Article

10 Does the 6-minute walk test predict nocturnal oxygen desaturation in patients with moderate to severe COPD? Chronic Respiratory Disease, January 27, 2015    Clinical Article

11 Hookah smoke exposure doubles dangerous benzene uptake American Association for Cancer Research News, December 1, 2014

12 Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: Impact on survival and bacterial resistance Critical Care, November 8, 2013    Clinical Article

13 Assessment of montelukast, doxofylline, and tiotropium with budesonide for the treatment of asthma: which is the best among the second-line treatment? a randomized trial Clinical Therapeutics, January 13, 2015    Clinical Article

14 Bronchodilator efficacy of tiotropium-formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD Pulmonary Pharmacology and Therapeutics, February 14, 2014    Clinical Article

15 A new quantitative index of lobar air trapping in chronic obstructive pulmonary disease (COPD): comparison with conventional methods European Journal of Radiology, January 23, 2015    Clinical Article

16 Phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease International Archives of Allergy and Immunology, January 16, 2015    Review Article

17 Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: A retrospective study Full Text BMC Anesthesiology, November 26, 2013    Free full text    Clinical Article

18 Efficacy and safety of a fixed-dose combination of indacaterol and glycopyrronium for the treatment of COPD: A systematic review Chest, August 21, 2014    Evidence Based Medicine

19 Is parent–child bed-sharing a risk for wheezing and asthma in early childhood? European Respiratory Journal , January 2, 2015    Clinical Article

20 Benefits of adding fluticasone propionate/salmeterol to tiotropium in COPD: A meta-analysis European Journal of Internal Medicine , June 17, 2014    Evidence Based Medicine    Review Article

Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicinemore

Looking for a physician job? Let us help!

Register now for our free job placement service.
A career consultant will contact you soon.
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List